To ensure users receive a high-quality device, CEO Søren Nielsen says Demant has lobbied the FDA through a US-based industry association as it attempts to established the rules for the upcoming over-the-counter hearing aids sales channel.
Demand for hearing aids on the US market will return in the future, according to Demant CEO Søren Nielsen, who thinks people are postponing the decision to acquire a device due to the challenging economic environment.
Last time the hearing aid manufacturer launched a product was during the pandemic. The market now is more open, meaning that there are more opportunities for physical launching events, says company CEO Gitte Aabo.
Genmab is recruiting to meet its goals for the future, which is intensifying the CEO role for Jan van de Winkel. Under his reign, the Danish biotech firm has gone from fewer than 200 people to 1,500 now.
A representative for the Novo Nordisk owner has refused to say whether the company received insider trading information about Convatec from the company’s former chairman, who has been fined for his involvement.
A new dose-sparing technique to extend the US supply of Bavarian Nordic’s monkeypox vaccine has been met with widespread safety concerns, with the vaccine maker’s CEO expressing ”reservations” about the method.
A number of conditions made it unfeasible for the Danish allergy firm to do business in Türkiye, says CEO Carsten Hellmann. Under a calculated and ruthless strategy to focus on markets with momentum, efforts in Italy and Spain have also been reduced.
For the rest of 2022, the Danish biotech firm will share all expenses relating to the development of Duohexabody-CD37 with Abbvie, despite the US-based firm’s decision to withdraw from the collaboration in question.
”I think this is a much simpler case than the first arbitration,” says Genmab CEO Jan van de Winkel on the new legal suit brought against Janssen, which stems from a fight Genmab has already lost once.